GSTM3 has been implicated in several cancers, with its protein expression exerting a significant influence on tumor progression or inhibition.84, 85, 86 The GSTM3 rs1055259 variant has been significantly allied with susceptibility to renal cell carcinoma, with evidence suggesting modifications in GSTM3 protein synthesis and reductions in reactive oxygen species activity, thereby affecting progression.87 This evidence concerns the gene GSTM3 and neoplasm.